JPH0214039B2 - - Google Patents

Info

Publication number
JPH0214039B2
JPH0214039B2 JP56112913A JP11291381A JPH0214039B2 JP H0214039 B2 JPH0214039 B2 JP H0214039B2 JP 56112913 A JP56112913 A JP 56112913A JP 11291381 A JP11291381 A JP 11291381A JP H0214039 B2 JPH0214039 B2 JP H0214039B2
Authority
JP
Japan
Prior art keywords
lymphotoxin
cells
human
animal
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP56112913A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5816687A (ja
Inventor
Masakazu Mihashi
Haruo Oonishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Mochida Pharmaceutical Co Ltd
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Mochida Pharmaceutical Co Ltd filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Priority to JP56112913A priority Critical patent/JPS5816687A/ja
Priority to SE8204382A priority patent/SE8204382L/xx
Priority to FR8212541A priority patent/FR2513124B1/fr
Priority to KR8203215A priority patent/KR870001433B1/ko
Priority to IT48855/82A priority patent/IT1196549B/it
Priority to AU86200/82A priority patent/AU560793B2/en
Priority to CH4420/82A priority patent/CH664974A5/fr
Priority to DE3227262A priority patent/DE3227262C3/de
Priority to DE3249946A priority patent/DE3249946C2/de
Priority to US06/400,487 priority patent/US4495282A/en
Priority to ES514210A priority patent/ES514210A0/es
Priority to AT0283582A priority patent/AT387980B/de
Priority to GB08221100A priority patent/GB2106117B/en
Publication of JPS5816687A publication Critical patent/JPS5816687A/ja
Priority to SE9000532A priority patent/SE9000532L/xx
Publication of JPH0214039B2 publication Critical patent/JPH0214039B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP56112913A 1981-07-21 1981-07-21 リンホトキシンの製造方法 Granted JPS5816687A (ja)

Priority Applications (14)

Application Number Priority Date Filing Date Title
JP56112913A JPS5816687A (ja) 1981-07-21 1981-07-21 リンホトキシンの製造方法
SE8204382A SE8204382L (sv) 1981-07-21 1982-07-19 Sett att framstella malcellysfaktor och anvendning derav
FR8212541A FR2513124B1 (fr) 1981-07-21 1982-07-19 Production et applications du facteur de lyse des cellules-cibles
KR8203215A KR870001433B1 (ko) 1981-07-21 1982-07-20 적상적혈구(的狀赤血球) 붕괴인자의 제조 방법
IT48855/82A IT1196549B (it) 1981-07-21 1982-07-20 Procedimento per la produzione del fattore di lisi cellule bersaglio (tclf),prodotto ottenuto a suo impiego in terapia clinica,in particolare come agente citolitico antitumurale
AU86200/82A AU560793B2 (en) 1981-07-21 1982-07-20 Production of target cell lysis factor
CH4420/82A CH664974A5 (fr) 1981-07-21 1982-07-20 Production du facteur de lyse des cellules-cibles.
DE3227262A DE3227262C3 (de) 1981-07-21 1982-07-21 Verfahren zur Herstellung von menschlichem Tumor-Nekrose-Faktor und menschlicher Tumor-Nekrose-Faktor
DE3249946A DE3249946C2 (de) 1981-07-21 1982-07-21 hTNF-haltiges therapeutisches Mittel gegen maligne Tumoren und dessen Verwendung
US06/400,487 US4495282A (en) 1981-07-21 1982-07-21 Process for producing target cell lysis factor and uses therewith
ES514210A ES514210A0 (es) 1981-07-21 1982-07-21 Un procedimiento para la produccion de tclf.
AT0283582A AT387980B (de) 1981-07-21 1982-07-21 Verfahren zur herstellung eines die aufloesung menschlicher zellen bewirkenden faktors
GB08221100A GB2106117B (en) 1981-07-21 1982-07-21 Process for producing target cell lysis factor
SE9000532A SE9000532L (sv) 1981-07-21 1990-02-14 Farmaceutisk tclf-komposition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56112913A JPS5816687A (ja) 1981-07-21 1981-07-21 リンホトキシンの製造方法

Publications (2)

Publication Number Publication Date
JPS5816687A JPS5816687A (ja) 1983-01-31
JPH0214039B2 true JPH0214039B2 (instruction) 1990-04-05

Family

ID=14598617

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56112913A Granted JPS5816687A (ja) 1981-07-21 1981-07-21 リンホトキシンの製造方法

Country Status (1)

Country Link
JP (1) JPS5816687A (instruction)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5821621A (ja) * 1981-07-31 1983-02-08 Hayashibara Biochem Lab Inc ヒトツモア・ネクロシス・ファクタ−を含有する悪性腫瘍治療剤
JPS5889195A (ja) * 1981-11-21 1983-05-27 Hayashibara Biochem Lab Inc 標的細胞障害性因子の製造方法
JPH0764744B2 (ja) * 1981-11-21 1995-07-12 株式会社林原生物化学研究所 標的細胞障害性因子とヒトインタ−フェロンとを有効成分として含有する悪性腫瘍治療剤
JP2518635B2 (ja) * 1981-07-31 1996-07-24 株式会社 林原生物化学研究所 ヒト ツモア・ネクロシス・フアクタ−
JP2518634B2 (ja) * 1981-07-31 1996-07-24 株式会社 林原生物化学研究所 ヒト ツモア・ネクロシス・フアクタ−の製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5498307A (en) * 1978-01-22 1979-08-03 Hayashibara Takeshi Production of interferon

Also Published As

Publication number Publication date
JPS5816687A (ja) 1983-01-31

Similar Documents

Publication Publication Date Title
US4621050A (en) Process for the production of human colony-stimulating factor
JPS631296B2 (instruction)
JPS6045849B2 (ja) ヒトエリトロポエチンの製造方法
JPS585671B2 (ja) ヒト卵胞刺激ホルモンの製造方法
JPS5852634B2 (ja) ウロキナ−ゼの製造法
JPS586475B2 (ja) ヒト絨毛性性腺刺激ホルモンの製造方法
JPH0214039B2 (instruction)
JPS6045848B2 (ja) ヒト成長ホルモンの製造方法
JPS58107197A (ja) ツモアネクロシスフアクタ−の製造方法
JP2926409B2 (ja) 癌転移抑制因子の製造方法
JPS5823793A (ja) ヒトｔ細胞増殖因子の製造方法
JPS6245208B2 (instruction)
JPH0446928B2 (instruction)
CA1295241C (en) Lymphokine and its production and uses
JPS5888322A (ja) 標的細胞障害性因子を含有する悪性腫瘍治療剤とその製造方法
KR970002165B1 (ko) γ-인터페론의 제조방법과 그 용도
KR830001817B1 (ko) 타이프ⅱ 인터페론의 제조방법
JP2532025B2 (ja) 新リンホカインｉｉｉを有効成分とする抗腫瘍作用を有するリンホカインの活性増強剤
JPS6045850B2 (ja) ヒト副腎皮質刺激ホルモンの製法
KR820001174B1 (ko) 사람 특이성 인터페론의 제조법
JP2518635B2 (ja) ヒト ツモア・ネクロシス・フアクタ−
JPH0523755B2 (instruction)
JPH0214038B2 (instruction)
JPH0526468B2 (instruction)
JPS61115099A (ja) モノクロ−ナル抗体とその製法